Granulocyte-macrophage colony stimulating factor (GM-CSF) as an adjunct to autologous bone marrow transplantation (ABMT) in hematology. Results of the interim analysis of the Schering-Plough/Sandoz International trial and considerations on increased safety in the transplant ward

Pathol Biol (Paris). 1992 Nov;39(9):954-5.

Authors

N C Gorin¹, L Fouillard

Affiliation

¹ Bone Marrow Transplant Unit, Hôpital Saint-Antoine, Paris, France.

PMID: 1538950

No abstract available

Publication types

Clinical Trial

MeSH terms

Bacterial Infections / etiology
Bacterial Infections / prevention & control*
Bone Marrow Transplantation / adverse effects*
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
Humans
Neutropenia / complications
Neutropenia / prevention & control*
Transplantation, Autologous

Substances

Granulocyte-Macrophage Colony-Stimulating Factor